Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Nonprescription Drugs Advisory Committee

This article was originally published in The Tan Sheet

Executive Summary

Eric Brass, MD/PhD, Harbor-UCLA Medical Center, to acting chair and heir apparent upon expiration of four-year term of former chair Ralph D'Agostino, PhD, Boston University on May 31. D'Agostino continues to participate in the committee as consultant who may vote on issues on a meeting-by-meeting basis. If Brass is to become chairman, his nomination will likely be approved in about two months, along with nominations to replace three other committee vacancies left by Cage Johnson, MD, University of Southern California, Beth Slingluff, Carondelet St. Mary's Hospital (Tucson, Ariz.) and Theodore Tong, University of Arizona College of Pharmacy...
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS088744

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel